This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Incyte Corp (INCY)

: Health Care

Company Cash Flow
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Cash Flow From Operating Activities
Net Income (Loss) 6.53M -48.48M -83.15M -44.32M
Operating Gains/Losses 0.00 0.00 17.93M -552.00K
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -56.52M -22.56M 35.58M -64.54M
(Increase) Decrease in Inventories 98.00K -4.09M -6.59M -5.22M
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables 5.62M 5.36M 5.14M -978.00K
(Decrease) Increase In Other Current Liabilities 25.25M 35.53M 27.19M 4.67M
(Increase) Decrease In Other Working Capital -12.88M -12.87M -66.05M -69.27M
Other Non-Cash Items 69.97M 62.44M 49.67M 38.49M
Net Cash From Continuing Operations 86.54M 26.26M 9.18M -94.83M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 86.54M 26.26M 9.18M -94.83M
Sale of Property, Plant & Equipment 0.00 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 68.97M 23.53M 583.00K 851.00K
Purchases of Property, Plant & Equipment -26.00M -27.88M -4.27M -2.84M
Acquisitions 0.00 0.00 0.00 0.00
Purchases of Short-Term Investments -108.15M -134.09M 0.00 0.00
Other Cash from Investing Activities 0.00 0.00 -33.71M 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities -105.01M -138.44M -37.40M -1.99M
Issuance of Debt 0.00 0.00 728.70M 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 86.44M 92.84M 73.16M 47.71M
Repayment of Long-Term Debt -1.70M 0.00 -511.48M 0.00
Repurchase of Capital Stock 0.00 0.00 0.00 0.00
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net 2.88M 213.00K -14.79M 0.00
Net Cash From Financing Activities 87.62M 93.06M 275.59M 47.71M
Effect of Exchange Rate Changes 0.00 -6.00K 0.00 0.00
Net Change in Cash & Cash Equivalents 69.14M -19.13M 247.37M -49.11M
INCY News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

Analysts Ratings for INCY

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 11 11 11 11
Moderate Buy 1 1 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET INCY ANALYST REPORT

INCY Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs